title: [Peritoneal biofilms: microscopic features].
abstract: Antibiotherapy remains one of the basic clinical tools, which can influence the evolution of severe peritonitis. Peritoneal biofilm formation may minimize the antibiotic effects due to dramatic growth of Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations (MBC) for matrix-enclosed bacteria. In this paper we demonstrate the presence and evolution of bacterial biofilms on the peritoneal surface during the course of severe secondary peritonitis using an experimental model and clinical material. Cecal Ligation Puncture was performed in 20 mice Swiss Webster. Peritoneal samples were studied at optic and electronic microscope at 10, 24, 48 and 72 hours postoperative. Clinical samples were taken from 10 patients with diffuse peritonitis. At 24 hours after the onset of the peritonitis bacterial colonies were detected on the peritoneal surface. The formation of mature multilayer polymicrobial biofilms with deep penetration in abdominal wall by 48-72 hours was documented. The bacterial biofilms appear in first 24 hours in the course of experimental generalized peritonitis. Our experimental and clinical data demonstrate formation of the mature polymicrobial biofilm in 48-72 hours after the onset of peritonitis. The possibility of resistant biofilm formation in secondary diffuse peritonitis should be taken into consideration in elaboration of treatment schemes.
authors.affiliation: Catedra Chirurgie, Facultatea de Perfecţionare a Medicilor, Universitatea de Stat de Medicina şi Farmacie "N. Testemiţanu", Spitalul Clinic Republican.
authors.forename: E
authors.initials: E
authors.lastname: Maloman
authors.forename: C
authors.initials: C
authors.lastname: Lepadatu
authors.forename: A
authors.initials: A
authors.lastname: Ciornâi
authors.forename: Natalia
authors.initials: N
authors.lastname: Sainsus
authors.forename: I
authors.initials: I
authors.lastname: Balica
authors.forename: N
authors.initials: N
authors.lastname: Gladun
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000254:growth & development*; D018441:Biofilms / Q000187:drug effects / Q000254:growth & development*; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008826:Microbial Sensitivity Tests; D008854:Microscopy, Electron; D010538:Peritonitis / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents